Talsaclidine

DB12287InvestigationalSmall molecule

Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M1, and Muscarinic acetylcholine receptor M2
Curator reviewed
Formula / weight: C₁₀H₁₅NO · 165.236 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyXVFJONKUSLSKSW-JTQLQIEISA-NSMILESC#CCO[C@H]1CN2CCC1CC2

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Talsaclidine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.